These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 7855220

  • 1. Differential effects of the serotonin1A agonist, 8-OH-DPAT, on masculine and feminine sexual behavior of the ferret.
    Paredes RG, Kica E, Baum MJ.
    Psychopharmacology (Berl); 1994 May; 114(4):591-6. PubMed ID: 7855220
    [Abstract] [Full Text] [Related]

  • 2. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
    Truitt W, Harrison L, Guptarak J, White S, Hiegel C, Uphouse L.
    Brain Res; 2003 Jun 06; 974(1-2):202-11. PubMed ID: 12742638
    [Abstract] [Full Text] [Related]

  • 3. Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT.
    Uphouse L, Maswood S, Jackson A, Brown K, Prullage J, Myers T, Shaheen F.
    Pharmacol Biochem Behav; 2002 Jun 06; 72(3):533-42. PubMed ID: 12175449
    [Abstract] [Full Text] [Related]

  • 4. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN.
    Uphouse L, Caldarola-Pastuszka M, Maswood S, Andrade M, Moore N.
    Brain Res; 1994 Feb 21; 637(1-2):173-80. PubMed ID: 8180795
    [Abstract] [Full Text] [Related]

  • 5. Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.
    Uphouse L, Maswood S, Jackson A.
    Pharmacol Biochem Behav; 2000 Jun 21; 66(2):383-8. PubMed ID: 10880694
    [Abstract] [Full Text] [Related]

  • 6. Reduced efficacy of 8-OH-DPAT's inhibition of lordosis behavior by prior estrogen treatment.
    Trevino A, Wolf A, Jackson A, Price T, Uphouse L.
    Horm Behav; 1999 Jun 21; 35(3):215-23. PubMed ID: 10373334
    [Abstract] [Full Text] [Related]

  • 7. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Jackson A, Uphouse L.
    Horm Behav; 1996 Jun 21; 30(2):145-52. PubMed ID: 8797023
    [Abstract] [Full Text] [Related]

  • 8. Estrogen modulates 5-HT(1A) agonist inhibition of lordosis behavior but not binding of [(3)H]-8-OH-DPAT.
    Jackson A, Etgen AM.
    Pharmacol Biochem Behav; 2001 Feb 21; 68(2):221-7. PubMed ID: 11267626
    [Abstract] [Full Text] [Related]

  • 9. Dose-dependent effects of estradiol benzoate on 5-HT1A receptor agonist action.
    Jackson A, Uphouse L.
    Brain Res; 1998 Jun 15; 796(1-2):299-302. PubMed ID: 9689482
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Brain region-specific transcriptomic markers of serotonin-1A receptor agonist action mediating sexual rejection and aggression in female marmoset monkeys.
    Aubert Y, Allers KA, Sommer B, de Kloet ER, Abbott DH, Datson NA.
    J Sex Med; 2013 Jun 15; 10(6):1461-75. PubMed ID: 23551660
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat.
    Ahlenius S, Fernandez-Guasti A, Hjorth S, Larsson K.
    Eur J Pharmacol; 1986 May 27; 124(3):361-3. PubMed ID: 2942412
    [Abstract] [Full Text] [Related]

  • 16. Modulation of sexual behaviour in the rat by a potent and selective alpha 2-adrenoceptor antagonist, delequamine (RS-15385-197).
    Tallentire D, McRae G, Spedding M, Clark R, Vickery B.
    Br J Pharmacol; 1996 May 27; 118(1):63-72. PubMed ID: 8733577
    [Abstract] [Full Text] [Related]

  • 17. Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets.
    Aubert Y, Bohl MA, Lange JR, Diol NR, Allers KA, Sommer B, Datson NA, Abbott DH.
    Psychoneuroendocrinology; 2013 Jan 27; 38(1):145-54. PubMed ID: 22727480
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of the 5-HT1A agonists, 5-hydroxy- and 5-methoxy-(3-di-n-propylamino)chroman, on female lordosis behavior.
    Uphouse L, Caldarola-Pastuszka M, Moore N.
    Neuropharmacology; 1993 Jul 27; 32(7):641-51. PubMed ID: 8361579
    [Abstract] [Full Text] [Related]

  • 19. Attenuating effects of prior oestradiol benzoate priming on 5-HT-mediated lordosis behavior in rats are dose-dependent.
    Siddiqui A, Shaharyar S.
    Acta Physiol Hung; 2007 Sep 27; 94(3):209-21. PubMed ID: 17853773
    [Abstract] [Full Text] [Related]

  • 20. 5-HT1A receptors: differential involvement in female and male sexual behavior in the rat.
    Mendelson SD, Gorzalka BB.
    Physiol Behav; 1986 Sep 27; 37(2):345-51. PubMed ID: 2942955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.